It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Recognition of promoters in bacterial RNA polymerases (RNAPs) is controlled by sigma subunits. The key sequence motif recognized by the sigma, the −10 promoter element, is located in the non-template strand of the double-stranded DNA molecule ~10 nucleotides upstream of the transcription start site. Here, we explain the mechanism by which the phage AR9 non-virion RNAP (nvRNAP), a bacterial RNAP homolog, recognizes the −10 element of its deoxyuridine-containing promoter in the template strand. The AR9 sigma-like subunit, the nvRNAP enzyme core, and the template strand together form two nucleotide base-accepting pockets whose shapes dictate the requirement for the conserved deoxyuridines. A single amino acid substitution in the AR9 sigma-like subunit allows one of these pockets to accept a thymine thus expanding the promoter consensus. Our work demonstrates the extent to which viruses can evolve host-derived multisubunit enzymes to make transcription of their own genes independent of the host.
Promoter recognition is a critical step in the initiation of transcription of DNA to RNA. Here, the authors describe a novel mechanism by which a phage-encoded RNA polymerase recognizes viral promoters containing deoxyuridines instead of thymidines.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Texas Medical Branch, Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964)
2 University of Texas Medical Branch, Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology and Molecular Biophysics, Galveston, USA (GRID:grid.176731.5) (ISNI:0000 0001 1547 9964); Skolkovo Institute of Science and Technology, Center of Life Sciences, Moscow, Russia (GRID:grid.454320.4) (ISNI:0000 0004 0555 3608)
3 Skolkovo Institute of Science and Technology, Center of Life Sciences, Moscow, Russia (GRID:grid.454320.4) (ISNI:0000 0004 0555 3608)
4 Rowan University School of Osteopathic Medicine at Stratford, Department of Cell Biology and Neuroscience, Stratford, USA (GRID:grid.262671.6) (ISNI:0000 0000 8828 4546)
5 DeepMind Technologies Limited, London, UK (GRID:grid.498210.6) (ISNI:0000 0004 5999 1726)
6 Skolkovo Institute of Science and Technology, Center of Life Sciences, Moscow, Russia (GRID:grid.454320.4) (ISNI:0000 0004 0555 3608); Russian Academy of Sciences, Institute of Molecular Genetics, Moscow, Russia (GRID:grid.4886.2) (ISNI:0000 0001 2192 9124); The State University of New Jersey, Waksman Institute for Microbiology, Rutgers, Piscataway, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796)